150 related articles for article (PubMed ID: 36884115)
21. Orphan nuclear receptor NR2F6 acts as an essential gatekeeper of Th17 CD4+ T cell effector functions.
Hermann-Kleiter N; Baier G
Cell Commun Signal; 2014 Jun; 12():38. PubMed ID: 24919548
[TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.
Kato M; Takano M; Miyamoto M; Sasaki N; Goto T; Tsuda H; Furuya K
J Gynecol Oncol; 2015 Jan; 26(1):40-5. PubMed ID: 25310854
[TBL] [Abstract][Full Text] [Related]
23. The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36.
Zhou B; Jia L; Zhang Z; Xiang L; Yuan Y; Zheng P; Liu B; Ren X; Bian H; Xie L; Li Y; Lu J; Zhang H; Lu Y
Adv Sci (Weinh); 2020 Nov; 7(21):2002273. PubMed ID: 33173745
[TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
25. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
26. Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer.
Zhang J; Meng H; Zhang M; Zhang C; Huang M; Yan C; Wang Z; Hou L; Yang L; Ling R
Endocr Relat Cancer; 2020 May; 27(5):309-323. PubMed ID: 32203934
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
[TBL] [Abstract][Full Text] [Related]
28. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
[TBL] [Abstract][Full Text] [Related]
29. Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis.
Klepsch V; Gerner RR; Klepsch S; Olson WJ; Tilg H; Moschen AR; Baier G; Hermann-Kleiter N
Gut; 2018 Aug; 67(8):1434-1444. PubMed ID: 28779026
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer.
Zong L; Mo S; Sun Z; Lu Z; Yu S; Chen J; Xiang Y
Mod Pathol; 2022 Feb; 35(2):266-273. PubMed ID: 34493823
[TBL] [Abstract][Full Text] [Related]
31. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity.
Hermann-Kleiter N; Gruber T; Lutz-Nicoladoni C; Thuille N; Fresser F; Labi V; Schiefermeier N; Warnecke M; Huber L; Villunger A; Eichele G; Kaminski S; Baier G
Immunity; 2008 Aug; 29(2):205-16. PubMed ID: 18701084
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinoma and Tumor-associated Immune Cells: Differences Between MLH1 Methylated and Nonmethylated Subgroups.
Kir G; Olgun ZC; Soylemez T; Aydin A; Demircan B; Kaya IA; McCluggage WG
Int J Gynecol Pathol; 2021 Nov; 40(6):575-586. PubMed ID: 33332859
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
[TBL] [Abstract][Full Text] [Related]
34. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
Zhang C; Yang Q
Front Oncol; 2020; 10():572203. PubMed ID: 33634012
[TBL] [Abstract][Full Text] [Related]
35. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
[TBL] [Abstract][Full Text] [Related]
36. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study.
Li Q; Cong R; Wang Y; Kong F; Ma J; Wu Q; Ma X
Gynecol Oncol; 2021 Jan; 160(1):91-98. PubMed ID: 33081984
[TBL] [Abstract][Full Text] [Related]
37. Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter.
Hermann-Kleiter N; Meisel M; Fresser F; Thuille N; Müller M; Roth L; Katopodis A; Baier G
J Autoimmun; 2012 Dec; 39(4):428-40. PubMed ID: 22921335
[TBL] [Abstract][Full Text] [Related]
38. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G
Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641
[TBL] [Abstract][Full Text] [Related]
39. Regulation of renin expression by the orphan nuclear receptors Nr2f2 and Nr2f6.
Weatherford ET; Liu X; Sigmund CD
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F1025-33. PubMed ID: 22278040
[TBL] [Abstract][Full Text] [Related]
40. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].
Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
